newsfilter
← Latest News
GlobeNewswire·

Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock

WALTHAM, Mass., March 24, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (NASDAQ:APLS), a global biopharmaceutical company and leader in complement, today announced the pricing of its underwritten public offering of 7,446,809 shares of its co